Patheon Announces Agreement to Sell Niagara-Burlington Manufacturing Business
Under the agreement, Pharmetics will acquire the assets, including equipment, facilities and land, at Patheon's facilities in Fort Erie and Burlington (Gateway Drive) in Ontario. Pharmetics will provide employment to the entire active workforce of about 250 commercial manufacturing employees at the two sites and, subject to assignment of third-party contracts, will continue to manufacture and supply all of the products currently manufactured at these sites. Collectively, the two sites currently serve 14 clients, manufacturing and packaging on their behalf about 60 over-the-counter pharmaceutical products in a range of dosage forms, including tablets, liquids and powders.
The transaction is expected to be completed on or about January 31, 2008, subject to closing conditions, including regulatory approvals and the assignment of client and other contracts. The purchase price for the business is $5.75 million plus working capital, subject to closing adjustments.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.